Kawamoto Ryuichi, Kohara Katsuhiko, Tabara Yasuharu, Miki Tetsuro, Ohtsuka Nobuyuki, Kusunoki Tomo, Yorimitsu Nobukazu
Department of Internal Medicine, Seiyo Municipal Nomura Hospital, Seiyo, Japan.
Hypertens Res. 2008 Aug;31(8):1559-64. doi: 10.1291/hypres.31.1559.
Chronic kidney disease (CKD) is a major public health problem. However, few studies have examined the significance of body mass index (BMI) as a risk factor for the development of CKD in the general Japanese population. Study participants without a clinical history of stroke, transient ischemic attack, myocardial infarction, angina or renal failure (754 men aged 56+/-15 [mean+/-SD] years and 962 women aged 59+/-13 years) were randomly recruited from a single community at the time of their annual health examination. We examined the relationship between increased weight (i.e., BMI) and renal function evaluated by the estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease Study Group equation. Increased BMI was consistently associated with reduced eGFR. Estimated GFR was lower in participants with upper normal body weight (BMI, 22.0 to 24.9 kg/m2) or who were overweight or obese (BMI>or=25 kg/m2), compared with participants with lower normal body weight (BMI, 18.5 to 21.9 kg/m2). Stepwise multiple regression analysis using eGFR as an objective variable, adjusted for various risk factors as explanatory variables, showed that BMI (beta=-0.075) was significantly and independently associated with eGFR, in addition to age, log triglycerides, low-density lipoprotein cholesterol and log fasting blood glucose. Compared with those with lower normal body weight, multivariate-adjusted odds ratios for moderately reduced renal function, defined as an eGFR<60 mL/min/1.73 m2, were 1.86 (1.01-3.42) for upper normal weight and 2.02 (1.01-4.03) for overweight or obese individuals. In conclusion, increased BMI is strongly associated with decreased eGFR in community-dwelling healthy persons.
慢性肾脏病(CKD)是一个主要的公共卫生问题。然而,在普通日本人群中,很少有研究探讨体重指数(BMI)作为CKD发生风险因素的重要性。在年度健康检查时,从一个社区随机招募了没有中风、短暂性脑缺血发作、心肌梗死、心绞痛或肾衰竭临床病史的研究参与者(754名年龄为56±15[均值±标准差]岁的男性和962名年龄为59±13岁的女性)。我们使用肾脏病膳食改良研究组方程,研究了体重增加(即BMI)与通过估算肾小球滤过率(eGFR)评估的肾功能之间的关系。BMI增加始终与eGFR降低相关。与正常体重较低(BMI,18.5至21.9kg/m²)的参与者相比,正常体重上限(BMI,22.0至24.9kg/m²)或超重或肥胖(BMI≥25kg/m²)的参与者的估算肾小球滤过率较低。以eGFR为目标变量,将各种风险因素作为解释变量进行逐步多元回归分析,结果显示,除年龄、甘油三酯对数、低密度脂蛋白胆固醇和空腹血糖对数外,BMI(β=-0.075)与eGFR显著且独立相关。与正常体重较低的人相比,对于定义为eGFR<60mL/min/1.73m²的肾功能中度降低,正常体重上限者的多变量调整比值比为1.86(1.01-3.42),超重或肥胖者为2.02(1.01-4.03)。总之,在社区居住的健康人群中,BMI增加与eGFR降低密切相关。